Promuneā¢ (CPG 7909 Injection) In Combination With Chemotherapy In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer, A Randomized, Multi-Center, Controlled, Phase 2 Study
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Efficacy- overall response rate (CR & PR) according to the RECIST criteria
Indeterminate
No
United States: Food and Drug Administration
C017
NCT00070629
May 2003
July 2007
Name | Location |
---|---|
Marshfield Clinic | Marshfield, Wisconsin 54449 |
University of Minnesota | Minneapolis, Minnesota 55455 |
Providence Portland Medical Center | Portland, Oregon 97213-3635 |
VA New Jersey Health Care System | East Orange, New Jersey 07018 |
Kentucky Cancer Clinic | Pikeville, Kentucky 41501 |
Office of Ronald Yanagihara | Gilroy, California 95020 |
Kenmar Research Institute, LLC | Los Angeles, California 90057 |
Comprehensive Cancer Center of the Dessert | Palm Springs, California 92262 |
Florida Cancer Specialist | Fort Myers, Florida 33901 |
Indiana Hematology and Oncology Associates | Indianapolis, Indiana 46202 |
Medical Center Vincennes | Vincennes, Indiana 47591 |
Southeast Nebraska Hematology Oncology Consultants, PC | Lincoln, Nebraska 68516 |
HemOnCare | Brooklyn, New York 11212 |
Cancer Care of Western North Carolina | Asheville, North Carolina 28801 |
Cancer Care Institute of Carolina | Aiken, South Carolina 29801 |
Charleston Hematology/Oncology, PA | Charleston, South Carolina 29403 |
The Family Cancer Center | Collierville, Tennessee 38017 |